构建和验证年轻宫癌患者的预后模型:基于受限立方线的年龄分层
Yuan Gong1, Feifei Gou1, Qingfeng Qin1
1Department of Gynaecology, Guizhou Provincial People's Hospital, Guiyang, 550001, China.
Scientific reports
|November 30, 2024
概括
新的预后模型准确地预测了年轻宫癌 (CC) 患者的结果. 这些模型的性能优于当前的FIGO分期系统,为这一人口群体提供了更好的生存预测.
科学领域:
- 在瘤学瘤学.
- 妇科瘤学 妇科瘤学
- 癌症流行病学 癌症流行病学
背景情况:
- 宫癌 (CC) 是年轻女性的主要死亡原因.
- 现有的预后模型缺乏年龄特定的定义和针对年轻CC患者的量身定制方法.
研究的目的:
- 为年轻的宫癌患者开发和验证新的,年龄特定的预后诺姆图.
- 将这些新模型的疗效与国际妇科和产科联合会 (FIGO) 的分期系统进行比较.
主要方法:
- 利用了来自监测,流行病学和最终结果 (SEER) 数据库 (2000-2019) 的数据.
- 对于年龄分层和Cox回归用于预后因素识别,使用了受限制的立方线分析.
- 使用培训和外部队列开发和验证了两种名ograms,用对应指数 (C-index),校准图和接收器操作特征 (ROC) 曲线进行评估.
主要成果:
- 确定了年轻CC的独立预后因素的阶段,瘤大小,等级,组织学类型和手术干预.
- 在培训和验证组中,开发的名录显示出高准确性和预测效率.
- 与2018年FIGO分期系统 (更高的AUC值) 相比,这些新型模型在预测整体存活率 (OS) 中表现出更好的表现.
结论:
- 这种新型的诺基图为年轻的宫癌患者提供了准确可靠的预后预测.
- 这些工具可以帮助临床医生估计预后,并可能改善患者管理.
- 开发的模型为这个特定的人口群体提供了与现有的分期系统相比的显著进步.
相关概念视频
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Survival Tree
61
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
Building a Survival Tree
Constructing a...
Building a Survival Tree
Constructing a...
61
Comparing the Survival Analysis of Two or More Groups
152
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
152


